Paul Manley

When Paul Manley began his career at MGS 25 years ago, the company was a small, $10 million tool shop. Today, it’s a $300 million global contract manufacturer servicing Fortune 100 healthcare OEMs in medical device and pharmaceutical markets.

Manley held several roles in the company during that time and put his stamp on things large and small as the company grew. Manley got his start at MGS as an accounts payable clerk, then moved on to staff accountant, controller, vice president of finance (Tooling Group), chief financial officer and now his current role as president and CEO.

Under Manley’s leadership as CFO, the company experienced 30% organic growth and doubled its position in the healthcare market. Manley’s leadership was also critical to the growth of the company’s molding business, including the development of MGS’ healthcare strategy.

He helped secure various acquisitions for MGS, including a 125,000-square-foot injection molding facility in Juarez, Mexico, from Florida-based Jabil Inc. in 2017 and most recently the acquisition of Formteknik, a European leader in innovative tooling solutions with operations in Denmark, Sweden and Germany.

Manley’s vision led MGS into the contract manufacturing space, drove expansion into six countries in North America and Europe, guided the business into the healthcare market and ultimately led to an enterprise employing over 1,600 people. Manley’s current role as CEO has allowed him to develop a five-person executive leadership team supported by a 35-member senior leadership team, resulting in career advancement and setting the foundation for the organization for decades to come, the company said.

“His high energy and clear vision are the driving forces behind the success and bright future for MGS,” Manley’s team said. “The deep connection Paul keeps with the employees at MGS help maintain a family atmosphere and make the company a fun place to work.”

During the pandemic, while many other manufacturers struggled, Manley led MGS to expand its operations and increase production to meet the demand for medical supplies.

“Paul’s dedication to the MGS team and his forward thinking kept MGS open and thriving through the COVID-19 pandemic,” Manley’s team said. “His perseverance allowed MGS’ customers to reap the benefit of the company’s single greatest differentiation: the ability to integrate our capabilities to design, execute and ramp up production quickly. Producing millions of COVID-19 test kit components in just 12 weeks would not have been possible without tapping the experience and cross-functional expertise inside the company.”